AI assistant
MEDIFAST INC — Director's Dealing 2024
Feb 16, 2024
33899_dirs_2024-02-16_d1249eb1-0932-4fc9-b1eb-fb0a567cc754.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2024-02-14
Reporting Person: Chard Daniel R (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-02-14 | Common Stock | A | 16486 | — | Acquired | 63614 | Direct |
| 2024-02-14 | Common Stock | F | 5471 | $52.68 | Disposed | 58143 | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 108598.352 | Indirect |
Footnotes
F1: 8,243 Performance Stock Units were granted on March 17, 2021, and vested on December 31, 2023 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 14, 2024 and the shares were released on February 14, 2024.
F2: These shares are directly owned by The Dan and Allyson Family Irrevocable Trust, for which the reporting person is the Settlor of the Trust and Investment Trustee.